PCM

Perkins Capital Management Portfolio holdings

AUM $133M Turnover 16.67%
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+53.73%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$26.3M
Cap. Flow
-$8.45M
Cap. Flow %
-6.35%
Top 10 Hldgs %
52.22%
Holding
90
New
4
Increased
8
Reduced
47
Closed
11
Avg Time Held
5.6 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
3 years

Top Buys

Rank Stock Value
1
CREX icon
Creative Realities
CREX
+$1.13M
2
VIDA icon
VIDA Global Inc
VIDA
+$971K
3
QTI icon
QT Imaging Holdings
QTI
+$556K
4
CXDO icon
Crexendo
CXDO
+$141K
5
PERI icon
Perion Network
PERI
+$79.6K

Top Sells

Rank Stock Value
1
INGN icon
Inogen
INGN
+$1.23M
2
QUIK icon
QuickLogic
QUIK
+$856K
3
AXGN icon
Axogen
AXGN
+$847K
4
NTRA icon
Natera
NTRA
+$788K
5
CPSH icon
CPS Technologies
CPSH
+$750K

Sector Composition

Rank Sector Weight
1 Healthcare 55.3%
2 Technology 28.21%
3 Communication Services 9.68%
4 Industrials 4.29%
5 Consumer Staples 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
COP icon
51
ConocoPhillips
COP
$171B
$483K 0.36%
4,650
-200
-4% -$23.7K
2024 Q1
9 quarters
NXPI icon
52
NXP Semiconductors
NXPI
$55.7B
$478K 0.36%
1,700
-100
-6% -$27.6K
2019 Q3
27 quarters
LFVN icon
53
LifeVantage
LFVN
$73M
$471K 0.35%
75,458
– –
2013 Q2
52 quarters
CELC icon
54
Celcuity
CELC
$2.93B
$471K 0.35%
4,500
-900
-17% -$104K
2025 Q1
5 quarters
GIS icon
55
General Mills
GIS
$17.2B
$434K 0.33%
8,375
-500
-6% -$17.3K
2017 Q4
34 quarters
SKYT icon
56
DELISTED
SkyWater Technology
SKYT
$414K 0.31%
11,900
-14,500
-55% -$496K
2022 Q4
14 quarters
BMY icon
57
Bristol-Myers Squibb
BMY
$121B
$414K 0.31%
7,180
-250
-3% -$14.4K
2017 Q3
35 quarters
DCI icon
58
Donaldson
DCI
$10.1B
$413K 0.31%
4,600
– –
2013 Q2
52 quarters
QTI icon
59
QT Imaging Holdings
QTI
$36.6M
$407K 0.31%
+100,000
New +$556K
2026 Q2
0 quarters
VZ icon
60
Verizon
VZ
$185B
$386K 0.29%
9,108
– –
2013 Q2
52 quarters
CSTL icon
61
Castle Biosciences
CSTL
$1.01B
$385K 0.29%
16,140
+725
+5% +$16.1K
2019 Q3
27 quarters
ELUT icon
62
Elutia
ELUT
$32.6M
$380K 0.29%
694,094
-62,800
-8% -$66.7K
2020 Q4
22 quarters
FAST icon
63
Fastenal
FAST
$59.7B
$348K 0.26%
7,250
– –
2017 Q4
34 quarters
T icon
64
AT&T
T
$158B
$331K 0.25%
15,992
– –
2015 Q3
43 quarters
BP icon
65
BP
BP
$126B
$320K 0.24%
8,650
-550
-6% -$24.1K
2021 Q3
19 quarters
JNJ icon
66
Johnson & Johnson
JNJ
$612B
$305K 0.23%
1,200
– –
2020 Q4
22 quarters
BLNE icon
67
Beeline Holdings
BLNE
$20.7M
$290K 0.22%
238,000
-7,000
-3% -$11.5K
2025 Q4
2 quarters
MRNA icon
68
Moderna
MRNA
$90.3B
$280K 0.21%
4,000
– –
2026 Q1
1 quarter
XGN icon
69
Exagen
XGN
$204M
$264K 0.2%
56,796
-15,000
-21% -$56.5K
2019 Q3
27 quarters
APYX icon
70
Apyx Medical
APYX
$108M
$189K 0.14%
42,000
– –
2022 Q1
17 quarters
AIRG icon
71
Airgain
AIRG
$53.1M
$139K 0.1%
22,000
– –
2018 Q3
31 quarters
PBYI icon
72
Puma Biotechnology
PBYI
$527M
$109K 0.08%
13,400
+900
+7% +$6.59K
2025 Q3
3 quarters
OPRX icon
73
OptimizeRx
OPRX
$156M
$84.7K 0.06%
14,808
-1,100
-7% -$6.32K
2018 Q2
32 quarters
IRIX icon
74
IRIDEX
IRIX
$14.5M
$81.1K 0.06%
70,800
+15,500
+28% +$16.6K
2015 Q2
44 quarters
CATX icon
75
Perspective Therapeutics
CATX
$256M
$62.1K 0.05%
+18,200
New +$68.8K
2026 Q2
0 quarters
1 2
3
4

Similar funds

AA
Alpha Advisors Richmond, Virginia $133M AUM 20.23% 1-Year Est. Return
WA
Winter & Associates St. Paul, Minnesota $133M AUM
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $133M AUM 50.19% 1-Year Est. Return
HAP
Harbor Asset Planning Belmont, Massachusetts $133M AUM 24.86% 1-Year Est. Return
RHIG
R.H. Investment Group Scottsdale, Arizona $133M AUM 23.61% 1-Year Est. Return
CWM
Capstone Wealth Management Billings, Montana $133M AUM
SI
Severin Investments St. Louis, Missouri $133M AUM 45.69% 1-Year Est. Return

Perkins Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Perkins Capital Management held 90 positions worth $133M, up 25% from $107M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Perkins Capital Management withdrew a net $8.45M in Q2 2026, closing 11 positions and reducing 47 holdings. Its most notable exit was Inogen, an estimated $1.23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Perkins Capital Management opened a new position in Creative Realities worth $1.24M.

  • Perkins Capital Management's largest Q2 2026 buy was Creative Realities: 300,050 shares worth $1.24M.
  • Perkins Capital Management added most to Crexendo in Q2 2026, an estimated $141K increase.
  • Perkins Capital Management's biggest Q2 2026 reduction was QuickLogic, cutting an estimated $856K.
  • Perkins Capital Management fully exited Inogen in Q2 2026, selling an estimated $1.23M.
  • Perkins Capital Management's ten largest holdings make up 52% of its $133M portfolio in Q2 2026.
  • Perkins Capital Management opened 4 new positions and closed 11 in Q2 2026.
  • Perkins Capital Management's portfolio value rose 25% quarter-over-quarter to $133M.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.